Serpentine Supravenous Hyperpigmentation Following Intravenous Docetaxel
Serpentine supravenous hyperpigmentation is a rare, cutaneous sequela of intravenous chemotherapeutic agents, collagen vascular diseases (systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis), and infections like leprosy and HIV. The condition manifests clinically as a peculiar...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Pigment International |
Subjects: | |
Online Access: | http://www.pigmentinternational.com/article.asp?issn=2349-5847;year=2021;volume=8;issue=2;spage=109;epage=111;aulast=Mondal |